BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2408614)

  • 21. Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors.
    Lee YL; Hintz RL; James PM; Lee PD; Shively JE; Powell DR
    Mol Endocrinol; 1988 May; 2(5):404-11. PubMed ID: 2458522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major secretory protein of human decidualized endometrium in pregnancy is an insulin-like growth factor-binding protein.
    Bell SC; Patel SR; Jackson JA; Waites GT
    J Endocrinol; 1988 Aug; 118(2):317-28. PubMed ID: 2459286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatomedin-C/insulin-like growth factor I-binding proteins in human amniotic fluid and in fetal and postnatal blood: evidence of immunological homology.
    D'Ercole AJ; Drop SL; Kortleve DJ
    J Clin Endocrinol Metab; 1985 Oct; 61(4):612-7. PubMed ID: 2411754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay.
    Chochinov RH; Mariz IK; Hajek AS; Daughaday WH
    J Clin Endocrinol Metab; 1977 May; 44(5):902-8. PubMed ID: 870516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of the rat type 1 insulin-like growth factor-binding protein by well differentiated H4EIIC3 hepatoma cells: identification, purification, and N-terminal amino acid analysis.
    Unterman TG; Oehler DT; Gotway MB; Morris PW
    Endocrinology; 1990 Aug; 127(2):789-97. PubMed ID: 2164920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II.
    Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF
    Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action.
    Mohan S; Bautista CM; Wergedal J; Baylink DJ
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8338-42. PubMed ID: 2479022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein.
    Wood WI; Cachianes G; Henzel WJ; Winslow GA; Spencer SA; Hellmiss R; Martin JL; Baxter RC
    Mol Endocrinol; 1988 Dec; 2(12):1176-85. PubMed ID: 2464130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The binding characteristics and biological effects in FRTL5 cells of placental protein-12, an insulin-like growth factor-binding protein purified from human amniotic fluid.
    Frauman AG; Tsuzaki S; Moses AC
    Endocrinology; 1989 May; 124(5):2289-96. PubMed ID: 2707157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Method for purification of an insulin-like growth factor-binding protein produced by human HEP G2 hepatoma cells.
    Powell DR; Lee PD; Shively JE; Eckenhausen M; Hintz RL
    J Chromatogr; 1987 Sep; 420(1):163-70. PubMed ID: 2822744
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of Multiplication-Stimulating Activity (MSA) carrier protein.
    Lyons RM; Smith GL
    Mol Cell Endocrinol; 1986 May; 45(2-3):263-70. PubMed ID: 2423396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of a fetal somatomedin from the sheep: similarity to insulin-like growth factor II.
    Hey AW; Browne CA; Thorburn GD
    Endocrinology; 1988 Jan; 122(1):12-21. PubMed ID: 3335201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk.
    Baxter RC; Zaltsman Z; Turtle JR
    J Clin Endocrinol Metab; 1984 Jun; 58(6):955-9. PubMed ID: 6202711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid.
    Claussen M; Zapf J; Braulke T
    Endocrinology; 1994 Apr; 134(4):1964-6. PubMed ID: 7511097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological cross-reactivity of multiplication-stimulating activity polypeptides.
    Moses AC; Nissley SP; Short PA; Rechler MM
    Eur J Biochem; 1980 Jan; 103(2):401-8. PubMed ID: 6153980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural studies, localization in tissue and clinical aspects of human endometrial proteins.
    Seppälä M; Riittinen L; Julkunen M; Koistinen R; Wahlström T; Iino K; Alfthan H; Stenman UH; Huhtala ML
    J Reprod Fertil Suppl; 1988; 36():127-41. PubMed ID: 3057195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 34 kilodalton insulin-like growth factor binding proteins in human cerebrospinal fluid and the A673 rhabdomyosarcoma cell line are human homologues of the rat BRL-3A binding protein.
    Romanus JA; Tseng LY; Yang YW; Rechler MM
    Biochem Biophys Res Commun; 1989 Sep; 163(2):875-81. PubMed ID: 2476983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of multiplication-stimulating activity (MSA) carrier protein.
    Knauer DJ; Wagner FW; Smith GL
    J Supramol Struct Cell Biochem; 1981; 15(2):177-91. PubMed ID: 6086006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of riboflavin carrier protein from human amniotic fluid.
    Prasad PD; Malhotra P; Karande AA; Adiga PR
    Biochem Int; 1992 Jul; 27(3):385-95. PubMed ID: 1417876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunochemical characterization and quantification of the sex steroid-binding protein (SBP) in human amniotic fluid.
    Auzelle MP; Tardivel-Lacombe J; Domingo M; Egloff M; Degrelle H
    Clin Chim Acta; 1987 Jul; 167(1):43-9. PubMed ID: 3117438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.